Valeant (VRX) August weekly volatility elevated as shares up in premarket on Q2 and outlook

Valeant Pharma (NYSE: VRX) is recently up $1.55 to $24 in the premarket on backs FY16 revenue guidance of $9.9B-$10.1B, compared to consensus $10.01B. August weekly call option implied volatility is at 147, August is at 109, September is at 84; compared to its 52-week range of 34 to 175.

You May Also Be Interested In

• iShares Silver Trust (SLV) spreader of 5K contracts of July 90 and 100 puts
• Meta Platforms (META) call put ratio 3.9 calls to 1 put with a focus on August 720 calls as share price up 8.8%
• Alcoa (AA) call put ratio 1 call to 1 put on 29K contracts as share price down 10%